user-group INVESTOR ACCESS
  1. Home
  2. /
  3. Venture Capital
  4. /
  5. MRM Health Reports Preclinical...

Venture Capital

MRM Health Reports Preclinical Results Showing a 9-Strain Bacterial Consortium Delays Non-Alcoholic Fatty Liver Disease Progression and Liver Fibrosis

6 June 2022

Download

Press Release
Download

Related News

  • Venture Capital
  • Recent investments & divestments

Mérieux Innovation 2 invests in HighLife Medical, a leading French MedTech company

arrow-up-right
  • Buyout
  • Other news

Mérieux Equity Partners announces the first closing of Mérieux Participations 5

arrow-up-right
  • Venture Capital
  • Recent investments & divestments

Mérieux Innovation 2 invests in Ona Therapeutics, a Spanish biopharmaceutical company

arrow-up-right